Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats

Kyu Tae Kang, Jennifer C Sullivan, Jennifer M. Sasser, John D. Imig, Jennifer S. Pollock

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

To determine the mechanism(s) involved in vasorelaxation of small arteries from hypertensive rats, normotensive (NORM), angiotensin II-infused (ANG), high-salt (HS), ANG high-salt (ANG/HS), placebo, and deoxycorticosterone acetate-salt rats were studied. Third-order mesenteric arteries from ANG or ANG/HS displayed decreased sensitivity to acetylcholine (ACh)-induced vasorelaxation compared with NORM or HS, respectively. Maximal relaxations were comparable between groups. Blockade of Ca-activated K channels had no effect on ANG versus blunting relaxation in NORM (log EC50: -6.8±0.1 versus -7.2±0.1 mol/L). NO synthase (NOS) inhibition abolished ACh-mediated relaxation in small arteries from ANG, ANG/HS, and deoxycorticosterone acetate-salt versus blunting relaxation in NORM, HS, and placebo (% maximal relaxation: ANG: 2.7±1.8; ANG/HS: 7.2±3.2; NORM: 91±3.1; HS: 82.1±13.3; deoxycorticosterone acetate-salt: 35.2±17.7; placebo: 79.3±10.3), indicating that NOS is the primary vasorelaxation pathway in these arteries from hypertensive rats. We hypothesized that NO/cGMP signaling and NOS-dependent H2O2 maintains vasorelaxation in small arteries from ANG. ACh increased NOS-dependent cGMP production, indicating that NO/cGMP signaling is present in small arteries from ANG (55.7±6.9 versus 30.5±5.1 pmol/mg), and ACh stimulated NOS-dependent H2O2 production (ACh: 2.8±0.2 μmol/mg; Nω-nitro-L-arginine methyl ester hydrochloride+ACh: 1.8±0.1 μmol/mg) in small arteries from ANG. H2O2 induced vasorelaxation and catalase blunted ACh-mediated vasorelaxation. In conclusion, Ca-activated K channel-mediated relaxation is dysfunctional in small mesenteric arteries from hypertensive rats, and the NOS pathway compensates to maintain vasorelaxation in these arteries through NOS-mediated cGMP and H2O2 production.

Original languageEnglish (US)
Pages (from-to)893-901
Number of pages9
JournalHypertension
Volume49
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

Vasodilation
Nitric Oxide Synthase
Arteries
Salts
Acetylcholine
Desoxycorticosterone
Acetates
Mesenteric Arteries
Placebos
Angiotensin II
Catalase
Arginine

Keywords

  • Aorta
  • Endothelium-dependent vasorelaxation
  • Hydrogen peroxide
  • Hypertension
  • Mesenteric arteries
  • NO

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. / Kang, Kyu Tae; Sullivan, Jennifer C; Sasser, Jennifer M.; Imig, John D.; Pollock, Jennifer S.

In: Hypertension, Vol. 49, No. 4, 01.04.2007, p. 893-901.

Research output: Contribution to journalArticle

Kang, Kyu Tae ; Sullivan, Jennifer C ; Sasser, Jennifer M. ; Imig, John D. ; Pollock, Jennifer S. / Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. In: Hypertension. 2007 ; Vol. 49, No. 4. pp. 893-901.
@article{da82726342c643808221bf25b55d7b6d,
title = "Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats",
abstract = "To determine the mechanism(s) involved in vasorelaxation of small arteries from hypertensive rats, normotensive (NORM), angiotensin II-infused (ANG), high-salt (HS), ANG high-salt (ANG/HS), placebo, and deoxycorticosterone acetate-salt rats were studied. Third-order mesenteric arteries from ANG or ANG/HS displayed decreased sensitivity to acetylcholine (ACh)-induced vasorelaxation compared with NORM or HS, respectively. Maximal relaxations were comparable between groups. Blockade of Ca-activated K channels had no effect on ANG versus blunting relaxation in NORM (log EC50: -6.8±0.1 versus -7.2±0.1 mol/L). NO synthase (NOS) inhibition abolished ACh-mediated relaxation in small arteries from ANG, ANG/HS, and deoxycorticosterone acetate-salt versus blunting relaxation in NORM, HS, and placebo ({\%} maximal relaxation: ANG: 2.7±1.8; ANG/HS: 7.2±3.2; NORM: 91±3.1; HS: 82.1±13.3; deoxycorticosterone acetate-salt: 35.2±17.7; placebo: 79.3±10.3), indicating that NOS is the primary vasorelaxation pathway in these arteries from hypertensive rats. We hypothesized that NO/cGMP signaling and NOS-dependent H2O2 maintains vasorelaxation in small arteries from ANG. ACh increased NOS-dependent cGMP production, indicating that NO/cGMP signaling is present in small arteries from ANG (55.7±6.9 versus 30.5±5.1 pmol/mg), and ACh stimulated NOS-dependent H2O2 production (ACh: 2.8±0.2 μmol/mg; Nω-nitro-L-arginine methyl ester hydrochloride+ACh: 1.8±0.1 μmol/mg) in small arteries from ANG. H2O2 induced vasorelaxation and catalase blunted ACh-mediated vasorelaxation. In conclusion, Ca-activated K channel-mediated relaxation is dysfunctional in small mesenteric arteries from hypertensive rats, and the NOS pathway compensates to maintain vasorelaxation in these arteries through NOS-mediated cGMP and H2O2 production.",
keywords = "Aorta, Endothelium-dependent vasorelaxation, Hydrogen peroxide, Hypertension, Mesenteric arteries, NO",
author = "Kang, {Kyu Tae} and Sullivan, {Jennifer C} and Sasser, {Jennifer M.} and Imig, {John D.} and Pollock, {Jennifer S.}",
year = "2007",
month = "4",
day = "1",
doi = "10.1161/01.HYP.0000259669.40991.1e",
language = "English (US)",
volume = "49",
pages = "893--901",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats

AU - Kang, Kyu Tae

AU - Sullivan, Jennifer C

AU - Sasser, Jennifer M.

AU - Imig, John D.

AU - Pollock, Jennifer S.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - To determine the mechanism(s) involved in vasorelaxation of small arteries from hypertensive rats, normotensive (NORM), angiotensin II-infused (ANG), high-salt (HS), ANG high-salt (ANG/HS), placebo, and deoxycorticosterone acetate-salt rats were studied. Third-order mesenteric arteries from ANG or ANG/HS displayed decreased sensitivity to acetylcholine (ACh)-induced vasorelaxation compared with NORM or HS, respectively. Maximal relaxations were comparable between groups. Blockade of Ca-activated K channels had no effect on ANG versus blunting relaxation in NORM (log EC50: -6.8±0.1 versus -7.2±0.1 mol/L). NO synthase (NOS) inhibition abolished ACh-mediated relaxation in small arteries from ANG, ANG/HS, and deoxycorticosterone acetate-salt versus blunting relaxation in NORM, HS, and placebo (% maximal relaxation: ANG: 2.7±1.8; ANG/HS: 7.2±3.2; NORM: 91±3.1; HS: 82.1±13.3; deoxycorticosterone acetate-salt: 35.2±17.7; placebo: 79.3±10.3), indicating that NOS is the primary vasorelaxation pathway in these arteries from hypertensive rats. We hypothesized that NO/cGMP signaling and NOS-dependent H2O2 maintains vasorelaxation in small arteries from ANG. ACh increased NOS-dependent cGMP production, indicating that NO/cGMP signaling is present in small arteries from ANG (55.7±6.9 versus 30.5±5.1 pmol/mg), and ACh stimulated NOS-dependent H2O2 production (ACh: 2.8±0.2 μmol/mg; Nω-nitro-L-arginine methyl ester hydrochloride+ACh: 1.8±0.1 μmol/mg) in small arteries from ANG. H2O2 induced vasorelaxation and catalase blunted ACh-mediated vasorelaxation. In conclusion, Ca-activated K channel-mediated relaxation is dysfunctional in small mesenteric arteries from hypertensive rats, and the NOS pathway compensates to maintain vasorelaxation in these arteries through NOS-mediated cGMP and H2O2 production.

AB - To determine the mechanism(s) involved in vasorelaxation of small arteries from hypertensive rats, normotensive (NORM), angiotensin II-infused (ANG), high-salt (HS), ANG high-salt (ANG/HS), placebo, and deoxycorticosterone acetate-salt rats were studied. Third-order mesenteric arteries from ANG or ANG/HS displayed decreased sensitivity to acetylcholine (ACh)-induced vasorelaxation compared with NORM or HS, respectively. Maximal relaxations were comparable between groups. Blockade of Ca-activated K channels had no effect on ANG versus blunting relaxation in NORM (log EC50: -6.8±0.1 versus -7.2±0.1 mol/L). NO synthase (NOS) inhibition abolished ACh-mediated relaxation in small arteries from ANG, ANG/HS, and deoxycorticosterone acetate-salt versus blunting relaxation in NORM, HS, and placebo (% maximal relaxation: ANG: 2.7±1.8; ANG/HS: 7.2±3.2; NORM: 91±3.1; HS: 82.1±13.3; deoxycorticosterone acetate-salt: 35.2±17.7; placebo: 79.3±10.3), indicating that NOS is the primary vasorelaxation pathway in these arteries from hypertensive rats. We hypothesized that NO/cGMP signaling and NOS-dependent H2O2 maintains vasorelaxation in small arteries from ANG. ACh increased NOS-dependent cGMP production, indicating that NO/cGMP signaling is present in small arteries from ANG (55.7±6.9 versus 30.5±5.1 pmol/mg), and ACh stimulated NOS-dependent H2O2 production (ACh: 2.8±0.2 μmol/mg; Nω-nitro-L-arginine methyl ester hydrochloride+ACh: 1.8±0.1 μmol/mg) in small arteries from ANG. H2O2 induced vasorelaxation and catalase blunted ACh-mediated vasorelaxation. In conclusion, Ca-activated K channel-mediated relaxation is dysfunctional in small mesenteric arteries from hypertensive rats, and the NOS pathway compensates to maintain vasorelaxation in these arteries through NOS-mediated cGMP and H2O2 production.

KW - Aorta

KW - Endothelium-dependent vasorelaxation

KW - Hydrogen peroxide

KW - Hypertension

KW - Mesenteric arteries

KW - NO

UR - http://www.scopus.com/inward/record.url?scp=34047218002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047218002&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000259669.40991.1e

DO - 10.1161/01.HYP.0000259669.40991.1e

M3 - Article

VL - 49

SP - 893

EP - 901

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -